For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Beam Therapeutics Inc.

USPTO Granted Patents = 18

Trademarks = 2

Forward Citations = 51

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Nicole Marie Gaudelli (10 out of 14 patents)

Michael S Packer (9 out of 13 patents)

Ian Slaymaker (8 out of 26 patents)

4. Yi Yu (8 out of 180 patents)

5. Seung-Joo Lee (7 out of 10 patents)

6. David A Born (7 out of 7 patents)

7. Jason Michael Gehrke (7 out of 12 patents)

8. Bernd Zetsche (7 out of 30 patents)

9. Gregory Lawrence Hamilton (3 out of 5 patents)

10. Cory Dane Sago (3 out of 3 patents)

11. Neeraj Narendra Patwardhan (2 out of 2 patents)

12. John Evans (2 out of 2 patents)

13. David Bryson (2 out of 2 patents)

14. David R Liu (1 out of 161 patents)

15. J Keith Joung (1 out of 79 patents)

18 patents: Sort by Forward Citations

1. 12622931 - Compositions and methods for treating alpha-1 antitrypsin deficiency (2026-05-12),

2. 12612618 - Nucleobase editors having reduced non-target deamination and assays for characterizing nucleobase editors (2026-04-28),

3. 12600971 - Modified immune cells having adenosine deaminase base editors for modifying a nucleobase in a target sequence (2026-04-14),

4. 12594301 - Compositions and methods for treatment of liquid cancers (2026-04-07),

5. 12576151 - Fratricide resistant modified immune cells and methods of using the same (2026-03-17),

6. 12529041 - Compositions and methods for delivering a nucleobase editing system (2026-01-20),

7. 12454694 - Compositions and methods for improving base editing (2025-10-28),

8. 12296053 - Nanomaterials comprising triols (2025-05-13),

9. 12268753 - Nanomaterials comprising a biodegradable feature (2025-04-08),

10. 12133884 - Methods of substituting pathogenic amino acids using programmable base editor systems (2024-11-05),

11. 12125145 - Systems and methods for implemented mixed reality in laboratory automation (2024-10-22),

12. 12059477 - Nanomaterials (2024-08-13),

13. 12016908 - Compositions and methods for treating hemoglobinopathies (2024-06-25),

14. 11795443 - Uses of adenosine base editors (2023-10-24),

15. 11752202 - Compositions and methods for treating hemoglobinopathies (2023-09-12),

Beam Therapeutics is a biotechnology company that is developing precision genetic medicines for patients with serious diseases. Using their proprietary CRISPR base editing technology, Beam is working to create a new class of therapies that can address a wide range of genetic mutations. The company is focused on advancing innovative treatments for diseases such as sickle cell disease, beta-thalassemia, and other genetic disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

18 Patents

#152 in Cambridge, MA

#1,097 in Massachusetts

#17,922 in US

#34,120 in the World

Cambridge, MA, United States of America

Beam Therapeutics Inc.

Forward Citations = 51

29 inventors:

Nicole Marie Gaudelli (10 out of 14 patents)

Michael S Packer (9 out of 13 patents)

Ian Slaymaker (8 out of 26 patents)

4. Yi Yu (8 out of 180 patents)

5. Seung-Joo Lee (7 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…